Related references
Note: Only part of the references are listed.Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
Bernardo L. Rapoport et al.
FRONTIERS IN PHARMACOLOGY (2021)
Stereotactic ablative radiotherapy in operable stage I NSCLC patients: Long-term results of the expanded STARS clinical trial.
Joe Y. Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The Spectrum of Metastasis: An Opportunity for Cure?
Stanley Gutiontov et al.
SEMINARS IN RADIATION ONCOLOGY (2021)
Organ at Risk Dose Constraints in SABR : A Systematic Review of Active Clinical Trials
Serenna G. Gerhard et al.
PRACTICAL RADIATION ONCOLOGY (2021)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Matthias Guckenberger et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Feasibility of Optical Surface-Guidance for Position Verification and Monitoring of Stereotactic Body Radiotherapy in Deep-Inspiration Breath-Hold
Patrick Naumann et al.
FRONTIERS IN ONCOLOGY (2020)
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
David Ball et al.
LANCET ONCOLOGY (2019)
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
David A. Palma et al.
BMC CANCER (2019)
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Gilda Varricchi et al.
CURRENT MEDICINAL CHEMISTRY (2018)
The impact of technology on the changing practice of lung SBRT
Marianne Camille Aznar et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2018)
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy
R. J. Klement et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer
Robert D. Timmerman et al.
JAMA ONCOLOGY (2018)
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
Robert Olson et al.
BMC CANCER (2018)
IGRT and motion management during lung SBRT delivery
Vincent Caillet et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2017)
7-Year Follow-Up After Stereotactic Ablative Radiotherapy for Patients With Stage I Non-Small Cell Lung Cancer: Results of a Phase 2 Clinical Trial
Bing Sun et al.
CANCER (2017)
Deep Inspiration Breath Hold-Based Radiation Therapy: A Clinical Review
Judit Boda-Heggemann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases
Judit Boda-Heggemann et al.
RADIATION ONCOLOGY (2014)
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University
Vieri Scotti et al.
RADIOLOGIA MEDICA (2014)
Flattening-filter-free intensity modulated breath-hold image-guided SABR (Stereotactic ABlative Radiotherapy) can be applied in a 15-min treatment slot
Judit Boda-Heggemann et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Lung tumor reproducibility with active breath control (ABC) in image-guided radiotherapy based on cone-beam computed tomography with two registration methods
Xin Wang et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Multiple breath-hold CBCT for online image guided radiotherapy of lung tumors: Simulation with a dynamic phantom and first patient data
Judit Boda-Heggemann et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Short-term and long-term reproducibility of lung tumor position using active breathing control (ABC)
Rojano Koshani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
Y Seppenwoolde et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Share Paper
